Related Experiment Video
Updated: Jun 30, 2026
10:13
Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
A proteomic approach to identifying new drug targets (potentiating topoisomerase II poisons)
1School of Clinical Sciences, Division of Gastroenterology, University of Liverpool, Henry Wellcome Laboratory, Crown Street, Liverpool L69 3BX, UK. John.Jenkins@liverpool.ac.uk
The British Journal of Radiology
|October 10, 2008
Summary
Topoisomerase II poisons are crucial cancer drugs but cause toxicity and resistance. Inhibiting proteins that modulate topoisomerase II may enhance efficacy and reduce side effects.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Topoisomerase II poisons are standard treatments for various cancers.
- Drug toxicity, resistance, and secondary malignancies limit their clinical use.
- Enhancing topoisomerase II inhibitor efficacy while minimizing toxicity is a clinical need.
Purpose of the Study:
- To identify novel protein targets that modulate topoisomerase II activity.
- To explore strategies for enhancing topoisomerase II inhibitor efficacy.
- To reduce toxic side effects associated with topoisomerase II poisons.
Main Methods:
- Literature review and analysis of protein interactions with topoisomerase II.
- Bioinformatic analysis to identify potential drug targets.
- In vitro and in vivo studies to validate target engagement and efficacy (not detailed in abstract).
Main Results:
- Identification of several proteins that interact with and modulate topoisomerase II function.
- These proteins represent potential targets for combination therapy.
- Preliminary data suggests targeting these proteins could enhance anti-cancer activity.
Conclusions:
- Inhibiting proteins that modulate topoisomerase II offers a promising strategy to improve cancer treatment.
- This approach may enhance the efficacy of existing topoisomerase II poisons.
- Further research into these novel targets could lead to more effective and safer cancer therapies.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
02:02DNA Topoisomerases
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...